Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Institute on Drug Abuse (NIDA)
Phase I, Double-Blind, Placebo-Controlled Dose Escalating Assessment of Potential Interactions Between Intravenous Cocaine and RPR 102681
Age
18–45
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Includes but is not limited to:
Non-treatment seekers
DSM-IV criteria for cocaine abuse or dependence
Ability to verbalize understanding of consent form and provide written informed consent and verbalize willingness to complete study procedures; be able to comply with protocol requirements